Literature DB >> 18766492

Subtrochanteric displaced insufficiency fracture after long-term alendronate therapy--a case report.

Arkan S Sayed-Noor1, Göran O Sjödén.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18766492     DOI: 10.1080/17453670710015580

Source DB:  PubMed          Journal:  Acta Orthop        ISSN: 1745-3674            Impact factor:   3.717


× No keyword cloud information.
  14 in total

1.  Bisphosphonate-associated femur fractures have high complication rates with operative fixation.

Authors:  Mark L Prasarn; Jaimo Ahn; David L Helfet; Joseph M Lane; Dean G Lorich
Journal:  Clin Orthop Relat Res       Date:  2012-06-06       Impact factor: 4.176

2.  Histomorphometric and osteocytic characteristics of cortical bone in male subtrochanteric femoral shaft.

Authors:  Xiaoyu Tong; Markus K H Malo; Inari S Burton; Jukka S Jurvelin; Hanna Isaksson; Heikki Kröger
Journal:  J Anat       Date:  2017-08-07       Impact factor: 2.610

3.  Case reports: subtrochanteric femoral stress fractures after prolonged alendronate therapy.

Authors:  Katerina Cermak; Felix Shumelinsky; Jean Alexiou; Michael J Gebhart
Journal:  Clin Orthop Relat Res       Date:  2009-12-18       Impact factor: 4.176

4.  Femoral insufficiency fractures associated with prolonged bisphosphonate therapy.

Authors:  Joseph D Isaacs; Louis Shidiak; Ian A Harris; Zoltan L Szomor
Journal:  Clin Orthop Relat Res       Date:  2010-08-31       Impact factor: 4.176

5.  Incidence of stress fractures of the femoral shaft in women treated with bisphosphonate.

Authors:  Jörg Schilcher; Per Aspenberg
Journal:  Acta Orthop       Date:  2009-08       Impact factor: 3.717

6.  Case reports: two femoral insufficiency fractures after long-term alendronate therapy.

Authors:  Arkan S Sayed-Noor; Göran O Sjödén
Journal:  Clin Orthop Relat Res       Date:  2009-02-06       Impact factor: 4.176

Review 7.  Subtrochanteric fractures after long-term treatment with bisphosphonates: a European Society on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, and International Osteoporosis Foundation Working Group Report.

Authors:  R Rizzoli; K Akesson; M Bouxsein; J A Kanis; N Napoli; S Papapoulos; J-Y Reginster; C Cooper
Journal:  Osteoporos Int       Date:  2010-11-18       Impact factor: 4.507

8.  Oral bisphosphonates are associated with increased risk of subtrochanteric and diaphyseal fractures in elderly women: a nested case-control study.

Authors:  Juan Erviti; Alvaro Alonso; Belén Oliva; Javier Gorricho; Antonio López; Julia Timoner; Consuelo Huerta; Miguel Gil; Francisco De Abajo
Journal:  BMJ Open       Date:  2013-01-30       Impact factor: 2.692

Review 9.  Do bisphosphonates cause femoral insufficiency fractures?

Authors:  Andreas Seraphim; Nawfal Al-Hadithy; Simon C Mordecai; Shafic Al-Nammari
Journal:  J Orthop Traumatol       Date:  2012-08-01

10.  Spontaneous Incomplete transverse subtrochanteric femoral fracture with cortical thickening possibly secondary to risedronate use: a case report.

Authors:  Anas Alfahad; Ei Mon Thet; Fawzy Radwan; Joe Sudhakar; Khin Nini; Phaedra Tachtatzis
Journal:  J Med Case Rep       Date:  2012-09-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.